Navigation Links
Azantis Launches Liposomal Glutathione and Vitamin C.
Date:10/31/2011

BOULDER, Colo., Oct. 31, 2011 /PRNewswire/ -- Azantis launched today two innovative liposomal products: reduced glutathione and vitamin C. Both oral supplements are formulated in liposomal form to maximize absorption and to minimize side effects. Azantis, a leading phospholipid manufacturer, markets the liposomal products to resellers targeting the health care practitioner channel.

The liposomal glutathione contains 500 mg reduced glutathione per recommended daily dose.  These liposomes are highly stable with a very tight particle size range.  These features optimize the bioavailability of the glutathione cargo.

Glutathione is the body's most important intracellular sulfur bearing antioxidant, and the body's prime defense against toxins and oxidation. Low glutathione blood levels are commonly associated with poor health.

The vitamin C liposomes are designed to minimize intestinal discomfort, since certain individuals have difficulty tolerating vitamin C therapy at the clinically relevant higher doses. The recommended daily dosage is 1,000 mg vitamin C.  The vitamin C, as well as the glutathione liposomal product, is in liquid form.

"Reduced glutathione in liposomal form is superior, because of the maximized absorption. Oral administration of supplemental liposomes, when compared to IV and injections, allows a more even dosing of once or possibly several times per day," said Mickey Schuett, Director of Sales at Azantis Inc. "These products target foremost health care practitioners and resellers that market to these practitioners. The potency of this advanced delivery form is less suitable for the direct to consumer market."

Consumer information about liposomal glutathione and liposomal vitamin C can be readily found on the internet.

About Azantis

Azantis is a biotech company located in Boulder, Colorado. The company specializes in discovery and extraction of bioactive molecules from sustainable marine and other biomass sources for use in food, nutraceutical, and pharmaceutical products. Azantis' product offerings include omega 3 phospholipids and phospholipid liposomes.

Contact Mickey Schuett, 303-502-2400 or http://www.azantis.com/contact-us/


'/>"/>
SOURCE Azantis
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Azantis Announces New Consumer Safety Program
2. Australias Prince of Wales Hospital Launches New Era of Targeted Lung Cancer Treatments with Elektas Advanced 4D Motion Management Technology
3. Global Strategic Marketing Key to Success in Oncology Launches in the Pharmaceutical Sector
4. FHSSA Launches New Campaign to Partner US Hospices with Programs in Sub-Saharan Africa
5. nContact, Inc. Launches New Corporate Websites
6. First Response Launches IVF Fundraising Resource for Those Trying for a Baby
7. CDC Launches Effort to Protect Cancer Patients From Infections
8. Mylan Launches First Generic Version of Exelon® Capsules in the U.K.
9. Gamma Pharmaceuticals, Inc., Launches Retail Promotions for Gamma Energy Gel™ in New York City and Houston
10. Arthrosurface Launches Worlds First Talus Resurfacing Implant for the Ankle
11. DYMO® Labeling Launches High-Resolution Identification Scanner for Health Records Processing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Corporation ("Unilife" or "Company") (NASDAQ: UNIS ; ASX: UNS), ... its financial results for the second quarter of fiscal 2016 (three ... Financial Results for the Second Quarter of ... Revenue for the second quarter of fiscal 2016 was $4.5 ... Cash receipts from customers for the second quarter of fiscal 2016 ...
(Date:2/9/2016)... February 9, 2016 ... heute den Abschluss eines Kooperationsvertrags mit 10x ... Lösungen in den Bereichen Next-Generation-Sequencing (NGS), Single-Cell-Biology ... ; Frankfurt Prime Standard: QIA) gab heute ... für die Entwicklung und Förderung umfassender Lösungen ...
(Date:2/9/2016)... February 9, 2016 QGEN ... collaboration with 10x Genomics to develop and promote ... and bioinformatics. --> QGEN ; Frankfurt ... 10x Genomics to develop and promote comprehensive solutions ... --> QIAGEN N.V. (NASDAQ: QGEN ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading ... the fourth quarter and full year ended December 31, 2015 on Monday, February 29, ... webcast for the investment community following the release at 4:30 PM ET. Investors interested ...
(Date:2/10/2016)... Carefree, AZ (PRWEB) , ... February 10, 2016 , ... ... coach in new book , Pioneering book "Better with Age: The Ultimate Guide to ... neuroplasticity can improve memory. The book’s publication date is March 16, 2016. ...
(Date:2/10/2016)... MA (PRWEB) , ... February 10, 2016 , ... ... their revolutionary, biocompatible columns and accessories. These PEEK-lined stainless steel (PLS) columns combine ... provide a solution that ensures the integrity of biological samples while operating at ...
(Date:2/10/2016)... ... February 10, 2016 , ... The recreational use of marijuana has been ... still face a lot of restrictions as to where they can smoke pot. ... use” and that cannabis “may not be consumed openly or publicly.” , Given the ...
(Date:2/10/2016)... ... February 09, 2016 , ... ... Face and Body Specialists are delighted to welcome a new addition to their ... Face and Body Specialists as a nurse practitioner performing cosmetic procedures ...
Breaking Medicine News(10 mins):